Rheumatoid Arthritis Market is Expected to Increase from $ 80.7 Billion in 2020 : Radiant Insights , Inc
“ The market for disease-modifying RA therapeutics is expected to increase from $ 56.6 billion in 2013 to $ 80.7 billion in 2020 , at a Compound Annual Growth Rate ( CAGR ) of 5.2 %.”
Summary
Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid Arthritis Patients
Rheumatoid Arthritis ( RA ) is a chronic , progressive and currently incurable autoimmune disease that primarily affects joints . It is characterized by synovial inflammation and gradual bone erosion over many years , and disease progression results in stiffness and pain , especially in the hands and feet , which hinders patient mobility . Without treatment , the disease leads to joint destruction and disability . Prior to 1998 , treatment options were limited to small-molecule disease-modifying therapies , such as Methotrexate ( MTX ), sulfasalazine and anti-malarials . However , while MTX is efficacious in controlling RA symptoms in a large percentage of patients , approximately 33 % are unresponsive to these first-line drugs . The approval of revolutionary biological therapies ,
View summary of this report @ http :// www . radiantinsights . com / research / rheumatoidarthritis-market-to-2020-a-crowded-market-characterized-by-modest-growth
Follow Us :